Azala

Sudden Cardiac Death: Clinical Updates and Perspectives

Sudden cardiac death (SCD) affects more than four million patients per year worldwide, and accounts for up to 50% of all cardiovascular deaths. Related to the improved treatment options for cardiovascular diseases during the past several decades (e.g., improved guideline adherence to pharmacotherapi...

Deskribapen osoa

Gorde:
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2023
Gaiak:
ventricular tachycardia
ventricular fibrillation
mortality
ACE inhibitor
ARB
medical treatment
pharmacological drugs
gamma-glutamyl transferase
metabolic syndrome
sudden cardiac death
ammonia
cardiopulmonary resuscitation
neurological outcome
biomarkers
cardiac arrest
intensive care
levosimendan
inotropy
ventricular tachyarrhythmias
cardiac troponin I
coronary artery disease
n/a
coronary angiography
neurological sequelae
quality of life
temporal variability
COVID-19
coronavirus
out-of-hospital cardiac arrest (OHCA)
resuscitation
porcine
ventilation
MIGET
EIT
airway management
advanced life support
emergency medical service
tracheal intubation
videolaryngoscopy
intra-arrest hypothermia
sudden cardiac arrest
N-terminal of the prohormone brain natriuretic peptide predicts postoperative (NT-proBNP)
valve surgery
emergency treatment
invasive procedures
heart massage
circulation
clamshell thoracotomy
extra-corporeal membrane oxygenation
echocardiography
resuscitative endovascular balloon occlusion of the aorta
out-of-hospital cardiac arrest
quality improvement
ROSC
ambulance crew
underweight
diabetes mellitus
body-mass index
waist circumference
central obesity
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJD Cardiovascular medicine
Sarrera elektronikoa:ONIX_20231130_9783036591988_108
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Gaia:Sudden cardiac death (SCD) affects more than four million patients per year worldwide, and accounts for up to 50% of all cardiovascular deaths. Related to the improved treatment options for cardiovascular diseases during the past several decades (e.g., improved guideline adherence to pharmacotherapies, increasing supply with cardiac devices, and better revascularization strategies), the characteristics of patients presenting with SCD have significantly changed, making risk prediction for SCD even more complex. The present Special Issue reprint addresses the prognostic impact of patients’ characteristics (such as body mass index), airway and ventilation management in patients needing cardiopulmonary resuscitation, and the prognostic value of a targeted ambulance treatment quality improvement programme. Furthermore, the prognostic value of blood-derived biomarkers and cardiac pharmacotherapies for the prevention of SCD was investigated.

Antzeko izenburuak